Five years after COVID, pharma shares languish in US policy limbo
By Danilo Masoni MILAN (Reuters) -Global healthcare stocks have not been this cheap in decades and f...
23rd July, 2025
By Danilo Masoni MILAN (Reuters) -Global healthcare stocks have not been this cheap in decades and f...
23rd July, 2025
By Rishika Sadam HYDERABAD (Reuters) -Dr Reddy's Laboratories plans to launch a cheaper copycat vers...
23rd July, 2025
(Reuters) -GSK shares fell more than 6% on Friday after a U.S. FDA advisory panel recommended agains...
18th July, 2025

LONDON (Reuters) -Britain launched a life sciences sector plan on Wednesday to a mixed response from...
16th July, 2025
LONDON (Reuters) -Britain said it would strike an agreement with Vietnam to make it easier for pharm...
13th July, 2025

LONDON (Reuters) -The British government and the pharmaceutical industry remain far apart in a dispu...
2nd July, 2025
(Reuters) -AstraZeneca CEO Pascal Soriot is considering moving the company's stock market listing to...
1st July, 2025
DUBLIN (Reuters) - Ireland's gross domestic product grew by a hefty 9.7% quarter-on-quarter in the f...
5th June, 2025
(Reuters) -The Court of Appeal has upheld a British watchdog's 99 million pound ($131.94 million) fi...
8th May, 2025
By Julia Payne and Maggie Fick BRUSSELS/LONDON (Reuters) -The European Commission aims to reduce the...
11th March, 2025
(Reuters) - Drug compounders on Monday sued the U.S. Food and Drug Administration over its decision...
24th February, 2025

(Reuters) - FibroGen said on Thursday that it has sold its China unit to AstraZeneca for about $160...
20th February, 2025